| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |